T1	Participants 105 129	resectable rectal cancer
T2	Participants 383 486	multicentre phase-III European Organization for Research and Treatment of Cancer (EORTC) clinical trial
T3	Participants 488 587	Twelve radiotherapy departments with more than 10% of the evaluable patients recruited in the trial
